Markets
MTP

European ADRs Marginally Higher as Pharma Stocks See Mixed Fortunes

An image of multiple stacks of coins
Credit: Shutterstock photo

American depository receipts of European stocks were 0.2% higher at 124.81 on the Bank of New York Mellon Europe ADR Index on Monday morning.

Gainers in Continental Europe were led by Flamel Technologies ( FLML ), a French pharmaceutical company, 4.7% higher, followed by Luxottica ( LUX ), a materials technology company, 3.1% higher and Orange ( ORAN ), a French telecommunication services company, up by 2.9%.

In the UK, Amarin ( AMRN ), a biopharmaceutical company, was 3.3% higher, followed by Midatech ( MTP ), an early-stage biopharmaceutical company, up by 1.1% and Royal Bank of Scotland (RBS), 1.0% higher.

Decliners in Continental Europe were led by CGG (CGG), a manufacturer of geophysical equipment, 3.1% lower, followed by Ascendis Pharma (ASND), a Danish clinical stage biopharmaceutical company, down by 2.8% and Eni (E), an oil and gas exploration and production company, 2.3% lower.

And, in the UK, Adaptimmune Therapeutics (ADAP), a clinical-stage biopharmaceutical company, was 2.1% lower, followed by Trinity Biotech (TRIB), a manufacturer of medical diagnostic products, down by 1.6% and Luxfer (LXFR), a company specializing in the design, manufacture and supply of high-performance materials, trading 1.3% lower.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

MTP AMRN ORAN

Other Topics

Stocks

Latest Markets Videos